Publications
Publications
- ALL
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1997
- 1996
2025
| 06 | Long-term exposure to excessive norepinephrine in the brain induces tau aggregation, neuronal death, and cognitive deficits in early tau transgenic mice Jeong JH, Kim DK, Chung S, Han JW, Han J, Mook-Jung I. Aging Cell. 2025 Mar;24(3):e14420. |
Link |
|---|---|---|
| 05 | 25-Hydroxycholesterol modulates microglial function and exacerbates Alzheimer's disease pathology: mechanistic insights and therapeutic potential of cholesterol esterification inhibition Choi H, Kim HJ, Lee SE, Song HH, Kim J, Han J, Jeong JH, Lee DY, Chang S, Mook-Jung I.J Neuroinflammation. 2025 Feb 25;22(1):50. |
Link |
| 04 | Metabolic Reprogramming in Primary Microglial Cell and Extracellular Vesicle Triggered by Aβ Exposure Bong SH, Choi H, Song HH, Kim DK, Mook-Jung I, Lee DY. J Neurochem. 2025 Mar;169(3):e70030 |
Link |
| 03 | Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research Jung ES, Choi H, Mook-Jung I.Mol Neurodegener. 2025 Mar 27;20(1):37. |
Link |
| 02 | SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer's Disease Han J, Song J, Jung ES, Choi JW, Ji HY, Mook-Jung I.Aging Cell. 2025 Aug;24(8):e70101. 2025 May 10. |
Link |
| 01 | Monitoring the Dynamics of Alzheimer's Disease Biomarkers and the APOE-Tau Axis via Human Cerebral Organoids with Immuno-SERS Jo Y, Kim Y, Kang R, Lee S, Nguyen DD, Park S, Lee D, Han JW, Mook-Jung I, Lee LP, Park JC, Kim I.Adv Sci (Weinh). 2025 Sep;12(35):e05660. |
Link |